A clinical research on immuno-function of erythrocytes in the patients with pulmonary carcinoma.

Yuqiong Yang; Dezhi Hao; Yanping Wang; Xiaohe Chen; Ping LI; Wengeng Zhang; Zhiping LI

Return

A clinical research on immuno-function of erythrocytes in the patients with pulmonary carcinoma.

Author: Yuqiong YANG ¹ ; Dezhi HAO ; Yanping WANG ; Xiaohe CHEN ; Ping LI ; Wengeng ZHANG ; Zhiping LI
Author Information

1. Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, P.R.China.
Publication Type:Journal Article
From: Chinese Journal of Lung Cancer 2002;5(2):133-135
CountryChina
Language:Chinese
Abstract:
BACKGROUNDTo study the immuno-function of erythrocytes and the influence of surgical treatment on it in the patients with lung cancer.
METHODSA total of 61 patients with lung cancer were studied, consisting of 35 non-operative patients and 26 post-operative patients. Their immuno-function of erythrocytes was analyzed and compared with 30 normal controls.
RESULTSIn the post-operative group, the values of RBC C3BRRT and NTER were significantly higher than those of non-operative group (P < 0.01), but still lower than those of normal control group (P < 0.05); RFER, DTER, ETER and ATER higher than those of non-operative group (P < 0.01), and not significantly different from normal control group (P > 0.05); RBC ICR lower than that of non-operative group (P < 0.01), and not remarkably different from normal control group (P > 0.05); and RFIR lower than that of non-operative group (P < 0.01), however, still higher than that of normal control group (P < 0.01).
CONCLUSIONSThe immuno-function of erythrocytes may be related to body tumor load of the patients with lung cancer, and it may gradually recover after the primary tumor is resected.